Electronic health records and tumour-genome profiling offer promising real-world data with which to model cancer outcomes. Models built by using artificial intelligence (AI) to annotate clinical ...
Euan Ashley's lab explores the intricate interactions of gene variants. Tiny "typos," or genetic mutations, can sneak into ...
REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...
We used two cohorts for this study: (1) a Tempus cohort (TC) to investigate the genomic landscape and (2) a Stanford cohort (SC) where we include disease course and outcomes in addition to the genomic ...
The genomic drivers of coronary artery disease (CAD) are associated with the presentation of acute coronary syndromes and the severity and burden of angiographic CAD; these drivers also predict the ...
A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...
As cancer care increasingly shifts toward data-driven decision-making, 4baseCare is positioning itself at the intersection of genomics, AI, and clinical practice.The Bengaluru-based precision oncology ...
Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In today’s competitive healthcare landscape, innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results